Pharmacological actions of a novel, high-affinity, and selective human dopamine D3 receptor antagonist, SB-277011-A

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 3, 2000, Pages 1154-1165

  Reavill, C ^a   Taylor, S G ^a   Wood, M D ^a   Ashmeade, T ^a   Austin, N E ^a   Avenell, K Y ^a   Boyfield, I ^a   Branch, C L ^a   Cilia, J ^a   Coldwell, M C ^a   Hadley, M S ^a   Hunter, A J ^a   Jeffrey, P ^a   Jewitt, F ^a   Johnson, C N ^a   Jones, D N C ^a   Medhurst, A D ^a   Middlemiss, D N ^a   Nash, D J ^a   Riley, G J ^a   Routledge, C ^a   Stemp, G ^a   Thewlis, K M ^a   Trail, B ^a   Vong, A K K ^a   Hagan, J J ^a   more..

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 3 RECEPTOR BLOCKING AGENT; N[4 [2 (6 CYANO 1,2,3,4 TETRAHYDROISOQUINOLIN 2 YL)ETHYL]CYCLOHEXYL] 4 QUINOLININECARBOXAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CHO CELL; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DRUG PENETRATION; LIGAND BINDING; LOCOMOTION; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SCHIZOPHRENIA;

ANIMALS; BRAIN; CATALEPSY; CHO CELLS; CRICETINAE; DOPAMINE ANTAGONISTS; HUMANS; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NITRILES; PROLACTIN; QUINOLINES; RADIOLIGAND ASSAY; RATS; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STARTLE REACTION; TETRAHYDROISOQUINOLINES; TRANSFECTION;

EID: 0033838517     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. A targetted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice
2. Some quantitative uses of drug antagonists
3. 3 receptor antagonist SB-277011-A alters activity of midbrain dopamine midbrain neurons in rats: An in vivo electrophysiological study
4. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194
5. Nonlinear regression using spreadsheets
6. Modulation of cocaine self-administration in the rat through D3 dopamine receptors
7. 4.4 receptors expressed in Chinese hamster ovary cells
8. Central administration of dopamine D3 receptor antisense to rat: Effects on locomotion, dopamine release and [3H]spiperone binding
9. Chronic clozapine versus chronic haloperidol treatment: Differential effects on electrically evoked dopamine efflux in the rat caudate putamen, but not in the nucleus accumbens
10. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia
11. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: Comparison with D2 receptor expressing neurons
12. The use of quantitative RT-PCR to measure mRNA expression in a rat model of focal ischaemia - caspase-3 as a case study
13. Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability
14. Dopamine D3 receptors in the basal ganglia of the common marmoset and following MPTP and 1-Dopa treatment
15. SB-242084, a selective and brain penetrant 5-HT(2C) receptor antagonist
16. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice
17. Normalization of information processing deficits in schizophrenia with clozapine
18. The dopanfine D3 receptor: Chinese hamsters or Chinese whispers
19. Dopamine D3 receptor mRNA and binding sites in human brain
20. Differential distribution of D3 dopamine receptors in the brains of several mammalian species
21. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons
22. Allelic discrimination using fluorogenic probes and the 5'-nuclease assay
23. Statistical aspects of the analysis of data from retrospective studies of disease
24. S 14297, a novel selective ligand at cloned human dopamine D3 receptor, blocks 7-OH-DPAT-induced hypothermia in rats
25. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to to mesostriatal regions of human forebrain
26. Dopamine D3 receptor antisense influences dopamine synthesis in rat brain
27. 3 receptor agonist
28. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907
29. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice
30. A functional test identifies dopamine agonists selective for D3 versus D2 receptors
31. 3 receptor antagonist, activates locomotion in rodents
32. Dopamine D3 receptor: Basic and clinical aspects
33. The major dopamine D2 receptor: Molecular analysis of the human D(2A) subtype
34. 3) as a target for neuroleptics
35. D3 dopamine receptor mRNA is widely expressed in the human brain
36. Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons by antisense knockdown in vivo
37. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs
38. The dopamine D3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity
39. Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition
40. Dopamine D3 receptor mutant mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists
41. Dopamine D3 receptor mutant mice exhibit increased behavioural sensitivity to concurrent stimulation of D1 and D2 receptors